Join a live webinar led by Ashkan Emadi, MD, PhD  - Alexander Bland Osborn Endowed Chair and Distinguished Professor of Medical Oncology at West Virginia University School of Medicine and Physician-in-Chief, Medical Oncology, West Virginia University Health System & WVU Medicine Associate Center Director for Translational Research, WVU Cancer Institute along with and Lydia Benitez, PharmD, BCOP - Clinical Assistant Professor, University of Michigan College of Pharmacy (MI) focused on the current practice and identification of barriers to the evidence-based frontline management of ALL in the community setting. The goal is to facilitate peer-to-peer learning/discussion

ACCC’s Effective Care Coordination Practices Across the CAR T-Cell Therapy Care Continuum e-Course educates the multidisciplinary cancer care team on actionable solutions to improve patient access to CAR T-cell therapy and optimize care continuity between referring programs and CAR T-cell therapy centers.

Through this brief self-paced online eCourse, oncology professionals can better address the existing barriers to quality bladder cancer care for underserved populations and improve care coordination for improved health outcomes.

Join ACCC and speakers, Derek Allison, MD, director of the Molecular Tumor Board at Markey Cancer Center, and Justine Pickarski, MS, LGC, assistant director of the Molecular Tumor Board for an insightful webinar where participants will gain a comprehensive understanding of the structure and function of a molecular tumor board and its pivotal role in personalized cancer care. Explore the operations, workflows, and lessons learned at Markey Cancer Center and discover essential resources for establishing and maintaining an effective board at your own institution.

This session provides an overview of guideline development in the community setting for the utilization of BsAbs in patients.

This session provides an overview of the utilization of BsAbs in patients with follicular lymphoma.

This session provides an overview of the utilization of BsAbs in patients with cancer.

This session provides an overview of the utilization of BsAbs in patients with diffuse large b-cell lymphomas

This session provides an overview of the utilization of BsAbs in patients with multiple myeloma.